Research Paper Volume 15, Issue 18 pp 9521—9543
Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma
Figure 11. Investigation of drug sensitivity. (A–T) Boxplots of IC50 values for different agents in the two clusters.